Emeryville, CA, United States of America

David H Kirn

This inventor holds 16 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Adeno-Associated Virus. Top assignees: 4D Molecular Therapeutics Inc., 4 Molecular Therapeutics Inc., Ad Molecular Therapeutics Inc.. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David H Kirn. Retrieved from https://idiyas.com/inventor/david-h-kirn-3nz558td

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 11)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 8)

EPO Patents = 4 (Patent Applications = 11)

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 31(Granted Patents)

Company Filing History:

13 out of 15

4D Molecular Therapeutics Inc.

patents

1 out of 1

4 Molecular Therapeutics Inc.

patent

1 out of 1

Ad Molecular Therapeutics Inc.

patent

where one patent can have more than one assignee

Years Active: 2021-2025

Loading Chart...

Areas of Expertise:

Adeno-Associated Virus

Capsids

Retinal Disease

Gene Therapy

Codon Optimization

Angiogenesis

GLA Genes

REP1 Genes

RPGRORF15 Genes

Methods of Use

Treatments

Viral Vectors

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12221616 - Adeno-associated virus variant capsids and methods of use thereof (2025-02-11),

2. 11840704 - Adeno-associated virus variant capsids and methods of use thereof (2023-12-12),

3. 11802278 - Codon optimized GLA genes and uses thereof (2023-10-31),

4. 11766489 - Adeno-associated virus variant capsids and use for inhibiting angiogenesis (2023-09-26),

5. 11766487 - Treatments for retinal disease (2023-09-26),

6. 11613766 - Adeno-associated virus variant capsids and methods of use thereof (2023-03-28),

7. 11576983 - Treatments for retinal disease (2023-02-14),

8. 11524081 - Codon optimized REP1 genes and uses thereof (2022-12-13),

9. 11419949 - Adeno-associated virus variant capsids and methods of use thereof (2022-08-23),

10. 11364308 - Adeno-associated virus variant capsids and methods of use thereof (2022-06-21),

11. 11357870 - Codon optimized REP1 genes and uses thereof (2022-06-14),

12. 11345930 - Codon optimized RPGRORF15 genes and uses thereof (2022-05-31),

13. 11198858 - Codon optimized GLA genes and uses thereof (2021-12-14),

14. 11179477 - Method of using adeno-associated virus with variant capsid (2021-11-23),

15. 11167041 - Adeno-associated virus variant capsids and methods of use thereof (2021-11-09),

Title: The Innovative Journey of David H Kirn

Introduction: David H Kirn is a pioneering inventor based in Emeryville, California. With a passion for pushing the boundaries of innovation, Kirn has made significant contributions to the field of technology and beyond.

Latest Patents: David H Kirn holds several patents in various industries, showcasing his diverse range of expertise and creativity. His latest patents focus on cutting-edge technologies that aim to revolutionize the way we live and work.

Career Highlights: Throughout his illustrious career, David H Kirn has been at the forefront of groundbreaking inventions. His innovative spirit has led to the development of products and solutions that have had a lasting impact on society.

Collaborations: Kirn has collaborated with leading experts and organizations in the industry to bring his ideas to life. His ability to work effectively in teams and leverage collective knowledge has been instrumental in the success of his projects.

Conclusion: David H Kirn's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible make him a true visionary in the world of inventions. His work continues to inspire and shape the future of technology and beyond.

Profile summary based on public USPTO records.